HCV, HIV, & Substance Abuse – PLFV Chilliwack Conference

Chilliwack Hep C Conference by Positive Living Fraser Valley Feb. 17, 2017 was exciting and full of good info. Highlights for Hepcbc Hepatitis C Education-Prevention's attendee: (1) Dr.JOHN FARLEY stressing to healthcare workers the importance of testing EVERYONE for hepatitis B (HBV) before starting them on DAAs (new hep C treatments). You can have HBV and not know it, and it can become activated during DAA treatment. People are unexpectedly dying of

The Week in Review: Feb 10, 2017 – Feb 17, 2017

Friday, February 17, 2017 News Recap HCV & Heart Disease More and more I am hearing that people who have just finished treatment for HCV have had a stroke!  Our community really needs to know that hepatitis C is an independent risk factor for various kinds of heart disease: cerebrovascular events (strokes), and ischemic heart disease caused by atherosclerosis (plaque build-up in the arteries – particularly the coronary and carotid arteries, whic...

U.S.: Doctors, health officials want broad testing for hepatitis C

The Iowa Department of Public Health is calling for widespread testing for hepatitis C after a study showed cases in Iowa have almost tripled since 2000. Data shows the number of Iowans diagnosed with the hepatitis C virus increased from 754 in 2000 to 2,235 in 2015, a press release from department stated. The number of diagnoses among Iowans between 18 and 30 years old more than quadrupled since 2009, with 303 cases alone in 2015. After taking into ac

U.S.: Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact

Hepatitis C virus treatment is often restricted in Medicaid [in Canada this would be PharmaCare] patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo. The objectives of this study were to estimate change in chronic hepatitis C virus (HCV) disease and the economic burden associated with comprehensive treatment of the chronic HCV–infected Medicaid population. As has long been pred

Cirrhosis Increasing Among Hepatitis C Patients, According to Large US Study

The past decade has seen a nearly 40 percent increase in the prevalence of cirrhosis among people with hepatitis C in the U.S., a new study found. The reasons remain uncertain, however. The study, titled “Hepatitis C Complications: Prevalence and Disparities in a Large US Cohort 2006-2014” (abstract #180) was presented at The Liver Meeting 2016, held by the American Association for the Study of Liver Diseases (AASLD). Cirrhosis has long been linked t

Women’s Night – Stop HIV and Hepatitis C

"Ladies Night Out" in Port Coquitlam. Feb. 7th, 2017. Thanks to everyone for making this happen! Lower Mainland Stride with Purpose staff with Hepcbc Hepatitis C Education-Prevention 's Cheryl following an afternoon of fun, food, "pampering, HIV/HCV testing, Hep C BINGO and other games and prizes for many women who are not often pampered ...

Cost causing Canadians to say no to prescribed drugs

VANCOUVER (NEWS1130) – One in 12 Canadians 55 years and older have decided not to take drugs their doctor said they should take, based on the cost. This is according to a recently released study from UBC. This situation is causing people’s manageable health conditions to get worse, according to professor Steve Morgan with UBC’s school of population and public health, who says this costs us all more money in the end. But if Morgan is expecting a change,

Hepatitis C Patent Challenges In India, Argentina To Allow Generic Production

Resistance to high prices for hepatitis C drugs is ongoing as five new challenges against patents have been filed in India and Argentina, according to sources. Those challenges aim at allowing the production and distribution of affordable generic versions of new hepatitis C medicines (direct-acting antivirals). According to a Médecins Sans Frontières (MSF, Doctors Without Borders) press release, on 13 February the Initiative for Medicines, Access & Kn

Australia: Murray Bridge trials hepatitis C treatment project

Murray Bridge could be the first city in the world to eliminate hepatitis C when it hosts a national pilot project this March. Hepatitis SA are bringing a new revolution of treatment for the chronic disease to town in the effort to stop the spread of viral hepatitis worldwide by 2030. Despite an unprecedented number of Australians being cured of the disease in the past year, treatment uptake has proven slower in rural and regional areas. Murray Brid